Impact of Aerosol Box Use During Cardiopulmonary Arrest: A Multicenter Study (NCT05868239)
🩺 Plain-English Summary (8th-Grade Level)
Aerosol Generating Medical Procedures (AGMP) are procedures that have the potential to create tiny particles suspended in the air. These particles can contain germs such as viruses. The Coronavirus Disease 2019 (COVID-19) pandemic was caused by the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Patients infected with SARS-CoV-2 experience unusually high rates of critical illness that needs advanced airway management and intensive care unit admission. Bag-valve-mask (BVM) ventilation, endotracheal Intubation (ETI) and chest compressions are sometimes required for critically ill COVID-19 patients, and may contribute to a high risk of infection amongst Health Care Workers (HCW). To lessen HCW risk during high-risk procedures, a device called an aerosol box has been developed to place over the head of the patient, shielding the provider's face from virus droplets suspended in the air. The purpose of this research study is to better understand how particles disperse during AGMPs, more specifically during the provision of cardiopulmonary resuscitation (CPR). The project team hopes what is learned from the project can help inform infection control measures. This could help make changes to the clinical environment and make it safer for HCW's. The investigators intend to explore how an aerosol box performs in reducing contamination of HCW's who perform critical airway interventions during resuscitation events.
Who can join: Review the eligibility criteria below.
Location: Department of Emergency Medicine, Children's Hospital of Los Angeles — Los Angeles, California
Age range: 18 Years to 60 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (4 Sites)
- Department of Emergency Medicine, Children's Hospital of Los Angeles — Los Angeles, California
- KidSIM, Alberta Children's Hospital — Calgary, Alberta
- Department of Pediatrics, The Hospital for Sick Children — Toronto, Ontario
- Department of Pediatrics, CHU Sainte-Justine — Montreal, Quebec
📞 Contact the Study Coordinator
Phone: (403) 955-2633
Email: adam.cheng@albertahealthservices.ca
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Cardiac Arrest
- RACE-CARS - RAndomized Cluster Evaluation of Cardiac ARrest Systems — Durham, North Carolina
- Sustained Inflation and Chest Compression vs 3:1 C:V Ratio in Asphyxiated Newborns — Edmonton,
- Optimizing Ventilation to Improve Survival From Out-of-hospital Cardiac Arrest: the OPTIVO Randomized Controlled Trial — Toronto, Ontario
- Targeted Temperature Management at 33°C Versus Controlled Normothermia for In-hospital Cardiac Arrest — Brussels,
- Early Amiodarone in Shockable Cardiac Arrest — Portland, Oregon
Explore by condition: All Cardiac Arrest clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.